GenesisCare - logo
Enquire now
Refer a patient

Your state: AU |

down arrow down arrow

Basket–Solid Tumours

Basket–Solid Tumours
2022-01-19T00:00:00.000+11:00
Ongoing

Codebreak 101

Codebreak 101
Basket – Solid Tumours

A Phase 1b/2, Protocol Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of Sotorasib Monotherapy and in Combination With Other Anti-cancer Therapies in Subjects With Advanced Solid Tumours With KRAS p.G12C Mutation

To evaluate the safety and tolerability of sotorasib administered in investigational regimens in adult participants with KRAS p.G12C mutant advanced solid tumors.

Trial overview

Clinical Area

Medical Oncology

Disease / Condition

Basket – Solid Tumours

Study Phase

Ib/II

Trial Identifiers

Registration number: NCT04185883

https://clinicaltrials.gov/study/NCT04185883

GenesisCare Location(s)
Principal Investigator(s)
Medical Oncologist

Prof. Nick Pavlakis

BSc MBBS MMed PhD FRACP

Prof. Nick Pavlakis
Nick
Pavlakis
View Profile
Profile Image - Prof. Nick Pavlakis

Thank you for submitting.

We will be in touch within 24 hours

An unexpected error has occurred.

You will need to complete the form again, sorry for the inconvenience.

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

* Indicates a required field.

Disclaimer:

This website is provided for information purposes only. Nothing on this website is intended to be used as medical advice, or to diagnose, treat, cure or prevent any disease. It should not be used as a substitute for your own health professional's advice. Any medical procedure or treatment carries risks. Before proceeding with treatment, you should discuss the risks and benefits of the treatment with an appropriately qualified health practitioner. Individual treatment outcomes and experiences will vary.

You are leaving our website

You are now leaving our website. GenesisCare do not control this content and therefore are not responsible for its accuracy or reliability.